Recombinant multi-species hnRNP-E1/PCBP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine hnRNP-E1/PCBP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This intronless gene is thought to have been generated by retrotransposition of a fully processed PCBP-2 mRNA. This gene and PCBP-2 have paralogues (PCBP3 and PCBP4) which are thought to have arisen as a result of duplication events of entire genes. The protein encoded by this gene appears to be multifunctional. It along with PCBP-2 and hnRNPK corresponds to the major cellular poly(rC)-binding protein. It contains three K-homologous (KH) domains which may be involved in RNA binding. This encoded protein together with PCBP-2 also functions as translational coactivators of poliovirus RNA via a sequence-specific interaction with stem-loop IV of the IRES and promote poliovirus RNA replication by binding to its 5'-terminal cloverleaf structure. It has also been implicated in translational control of the 15-lipoxygenase mRNA, human Papillomavirus type 16 L2 mRNA, and hepatitis A virus RNA. The encoded protein is also suggested to play a part in formation of a sequence-specific alpha-globin mRNP complex which is associated with alpha-globin mRNA stability. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Alpha-CP1,HEL-S-85,HNRPE1,HNRPX,Heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1),Nucleic acid-binding protein SUB2.3,PCBP1,Pcbp1,Poly(rC)-binding protein 1,RGD1561319,WBP17,[a]CP-1,alphaCP-1,hnRNP E1,hnRNP-E1,hnRNP-X
Go
to hnRNP-E1/PCBP1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9229-Ag-1/ GM-Tg-hg-IP9229-Ag-2 | Human hnRNP-E1/PCBP1 protein | Human |
| GM-Tg-rg-IP9229-Ag-1/ GM-Tg-rg-IP9229-Ag-2 | Rat hnRNP-E1/PCBP1 protein | Rat |
| GM-Tg-mg-IP9229-Ag-1/ GM-Tg-mg-IP9229-Ag-2 | Mouse hnRNP-E1/PCBP1 protein | Mouse |
| GM-Tg-cynog-IP9229-Ag-1/ GM-Tg-cynog-IP9229-Ag-2 | Cynomolgus/Rhesus macaque hnRNP-E1/PCBP1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9229-Ag-1/ GM-Tg-felg-IP9229-Ag-2 | Feline hnRNP-E1/PCBP1 protein | Feline |
| GM-Tg-cang-IP9229-Ag-1/ GM-Tg-cang-IP9229-Ag-2 | Canine hnRNP-E1/PCBP1 protein | Canine |
| GM-Tg-bovg-IP9229-Ag-1/ GM-Tg-bovg-IP9229-Ag-2 | Bovine hnRNP-E1/PCBP1 protein | Bovine |
| GM-Tg-equg-IP9229-Ag-1/ GM-Tg-equg-IP9229-Ag-2 | Equine hnRNP-E1/PCBP1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9229-Ag-1/ GM-Tg-hg-IP9229-Ag-2;
GM-Tg-rg-IP9229-Ag-1/ GM-Tg-rg-IP9229-Ag-2;
GM-Tg-mg-IP9229-Ag-1/ GM-Tg-mg-IP9229-Ag-2; GM-Tg-cynog-IP9229-Ag-1/ GM-Tg-cynog-IP9229-Ag-2; GM-Tg-felg-IP9229-Ag-1/ GM-Tg-felg-IP9229-Ag-2; GM-Tg-cang-IP9229-Ag-1/ GM-Tg-cang-IP9229-Ag-2; GM-Tg-bovg-IP9229-Ag-1/ GM-Tg-bovg-IP9229-Ag-2; GM-Tg-equg-IP9229-Ag-1/ GM-Tg-equg-IP9229-Ag-2 |
| Products Name | hnRNP-E1/PCBP1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | hnRNP-E1/PCBP1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine hnRNP-E1/PCBP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.